Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

S Branford, S Moore, TP Hughes - Leukemia, 2006 - nature.com
Real-time quantitative polymerase chain reaction (PCR) for BCR-ABL mRNA in the
peripheral blood (RQ-PCR) provides an accurate and reliable measure of response to …
被引用次数：114 相关文章

Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

D Ross, S Branford, S Moore, T Hughes - 2006 - digital.library.adelaide.edu.au
Real-time quantitative polymerase chain reaction (PCR) for BCR-ABL mRNA in the
peripheral blood (RQ-PCR) provides an accurate and reliable measure of response to …
[PDF] researchgate.net

[PDF][PDF] Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

DM Ross, S Branford, S Moore, TP Hughes - Leukemia, 2006 - researchgate.net
Chronic myeloid leukaemia (CML) is defined by the presence of the bcr-abl fusion gene,
which results in expression of a constitutively activated tyrosine kinase that is essential for …

Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

DM Ross, S Branford, S Moore, TP Hughes - Leukemia, 2006 - go.gale.com
Real-time quantitative polymerase chain reaction (PCR) for BCR-ABL mRNA in the
peripheral blood (RQ-PCR) provides an accurate and reliable measure of response to …

[引用][C] Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

DM ROSS, S BRANFORD, S MOORE… - Leukemia, 2006 - pascal-francis.inist.fr
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic
phase CML patients monitored by RQ-PCR for BCR-ABL CNRS Inist Pascal-Francis CNRS …

[引用][C] Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

DM Ross, S Branford, S Moore, TP Hughes - Leukemia, 2006 - cir.nii.ac.jp
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic
phase CML patients monitored by RQ-PCR for BCR-ABL | CiNii Research CiNii 国立情報学 …

Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

DM Ross, S Branford, S Moore, TP Hughes - Leukemia, 2006 - researchnow.flinders.edu.au
Real-time quantitative polymerase chain reaction (PCR) for BCR-ABL mRNA in the
peripheral blood (RQ-PCR) provides an accurate and reliable measure of response to …

Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

DM Ross, S Branford, S Moore, T Hughes - Leukemia, 2006 - research.sahmri.org.au
Real-time quantitative polymerase chain reaction (PCR) for BCR-ABL mRNA in the
peripheral blood (RQ-PCR) provides an accurate and reliable measure of response to …

Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

DM Ross, S Branford, S Moore, TP Hughes - Leukemia, 2006 - pubmed.ncbi.nlm.nih.gov
Real-time quantitative polymerase chain reaction (PCR) for BCR-ABL mRNA in the
peripheral blood (RQ-PCR) provides an accurate and reliable measure of response to …

[引用][C] Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL

DM Ross, S Branford, S Moore, TP Hughes - Leukemia, 2006 - Nature Publishing Group